Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement
- PMID: 31265324
- DOI: 10.1152/ajpendo.00140.2019
Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement
Abstract
The gut bacterial species Akkermansia muciniphila is associated with a healthier clinical profile. The purpose of this study was to determine the association between A. muciniphila and glucose homeostasis in patients undergoing bariatric surgery (BS): gastric banding (GB) or Roux-en-Y gastric bypass (RYGB). This nonrandomized prospective study included 65 women with severe obesity. Longitudinal analysis included subjects for whom A. muciniphila data were available at follow-up [1, 3, and 12 mo; GB (n = 10) or RYGB (n = 11)]. Glucose homeostasis markers were measured under fasting conditions (glucose, insulin, and HbA1c) or during an oral glucose tolerance test. Fecal microbiota was analyzed using shotgun metagenomics, and A. muciniphila relative abundance was assessed with 16S rRNA quantitative PCR. A. muciniphila relative abundance was significantly lower in severe obesity [mean body mass index, 45.7 kg/m2 (SD 5.4)] than in moderate obesity [33.2 kg/m2 (SD 3.8)] but not associated with glucose homeostasis markers. A significant increase in A. muciniphila relative abundance after RYGB was not correlated with metabolic improvement. Baseline A. muciniphila abundance was correlated with bacterial gene richness and was highest in the high-richness Ruminococcaceae enterotype. A. muciniphila increased in relative abundance after BS in patients with low baseline A. muciniphila abundance, especially those with a Bacteroides type 2 enterotype classification. Although decreased in severe obesity, relative abundance of A. muciniphila was not associated with glucose homeostasis before or after BS. A certain level of A. muciniphila abundance might be required to observe a beneficial link to health. The severity of obesity and gut dysbiosis may partly explain the discrepancy with previous findings in less obese populations.
Keywords: bariatric surgery; dysbiosis; gut microbiota; severe obesity.
Similar articles
-
Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.Genome Med. 2016 Jun 15;8(1):67. doi: 10.1186/s13073-016-0312-1. Genome Med. 2016. PMID: 27306058 Free PMC article. Clinical Trial.
-
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery.Gut. 2019 Jan;68(1):70-82. doi: 10.1136/gutjnl-2018-316103. Epub 2018 Jun 13. Gut. 2019. PMID: 29899081 Free PMC article.
-
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.Gut. 2016 Mar;65(3):426-36. doi: 10.1136/gutjnl-2014-308778. Epub 2015 Jun 22. Gut. 2016. PMID: 26100928 Clinical Trial.
-
Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery.Curr Obes Rep. 2019 Sep;8(3):229-242. doi: 10.1007/s13679-019-00351-3. Curr Obes Rep. 2019. PMID: 31197613 Review.
-
THE INTESTINAL MICROBIOME IN PATIENTS UNDERGOING BARIATRIC SURGERY: A SYSTEMATIC REVIEW.Arq Bras Cir Dig. 2022 Dec 19;35:e1707. doi: 10.1590/0102-672020220002e1707. eCollection 2022. Arq Bras Cir Dig. 2022. PMID: 36542005 Free PMC article.
Cited by
-
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.Int J Mol Sci. 2022 Jan 6;23(2):594. doi: 10.3390/ijms23020594. Int J Mol Sci. 2022. PMID: 35054790 Free PMC article. Review.
-
Personalized Approach for Obese Patients Undergoing Endoscopic Sleeve Gastroplasty.J Pers Med. 2021 Dec 4;11(12):1298. doi: 10.3390/jpm11121298. J Pers Med. 2021. PMID: 34945770 Free PMC article. Review.
-
Akkermansia muciniphila-Nlrp3 is involved in the neuroprotection of phosphoglycerate mutase 5 deficiency in traumatic brain injury mice.Front Immunol. 2023 May 23;14:1172710. doi: 10.3389/fimmu.2023.1172710. eCollection 2023. Front Immunol. 2023. PMID: 37287985 Free PMC article.
-
Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice.Nat Microbiol. 2021 May;6(5):563-573. doi: 10.1038/s41564-021-00880-5. Epub 2021 Apr 5. Nat Microbiol. 2021. PMID: 33820962
-
Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism.Gut. 2023 May;72(5):906-917. doi: 10.1136/gutjnl-2021-326835. Epub 2023 Jan 16. Gut. 2023. PMID: 36646449 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials